Surface Phenomena Enhancing the Antibacterial and Osteogenic Ability of Nanocrystalline Hydroxyapatite, Activated by Multiple-Ion Doping
Source abstract
Abstract
The present work describes a novel nanocrystalline, multidoped hydroxyapatite featuring excellent eukaryotic versus prokaryotic cell selectivity, attested by excellent osteoinductive character and evaluated with human stem cells, and anti-infective ability, tested against different pathogens. Physicochemical analysis and transmission electron microscopy (TEM)/scanning STEM observations highlighted that such enhanced biological features are related to the lower crystallinity level and increased surface charge of hydroxyapatite, both induced by multiple-ion doping. Specifically, the lattice substitution of Ca2+ with Zn2+ promotes the segregation of Ca2+ and doping Mg2+ cations to a less-ordered surface layer, thus promoting dynamic ion absorption/release acting as bioactive signals for cells and exerting an antiproliferative effect on all tested pathogens. These findings open the design of new biodevices, combining regenerative ability and effective microbial inhibition without using any antibiotic drugs. This is extremely important to circumvent bacterial resistance to antibiotics, which is today considered as one of the biggest threats to global health.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Academic integrity and plagiarism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza 48018, Italy
Laboratory of Bio-inspired & Graphene Nanomechanics, Department of Civil, Environmental and Mechanical Engineering, University of Trento, Via Mesiano 77, 38123 Trento, Italy
Institute of Microbiology, University of Ferrara, Ferrara 44121, Italy
School of Engineering and Materials Science, Queen Mary University of London, Mile End Road, London E1 4NS, U.K.
Ket-Lab, Edoardo Amaldi Foundation, Via del Politecnico, 00133 Rome, Italy
References (53)
Show source-provided references
1. 10.1002/jor.2365610.1002/jor.23656 ↗
2. 10.1038/s41579-018-0125-x10.1038/s41579-018-0125-x ↗
3. 10.1186/s12951-017-0308-z10.1186/s12951-017-0308-z ↗
4. 10.1186/1743-8977-11-1110.1186/1743-8977-11-11 ↗
5. 10.3109/17435390.2011.62653810.3109/17435390.2011.626538 ↗
6. 10.2147/IJN.S13452610.2147/IJN.S134526 ↗
7. 10.1021/acsami.8b1278410.1021/acsami.8b12784 ↗
8. 10.1007/s10856-012-4817-x10.1007/s10856-012-4817-x ↗
9. 10.1007/s10856-012-4817-x10.1007/s10856-012-4817-x ↗
10. 10.1039/c8bm01145a10.1039/c8bm01145a ↗
11. 10.1016/S0753-3322(03)00081-710.1016/S0753-3322(03)00081-7 ↗
12. 10.1007/s10856-006-0032-y10.1007/s10856-006-0032-y ↗
13. 10.1007/BF0029677510.1007/BF00296775 ↗
14. 10.1016/j.msec.2006.11.00910.1016/j.msec.2006.11.009 ↗
15. 10.1016/j.jeurceramsoc.2005.06.04010.1016/j.jeurceramsoc.2005.06.040 ↗
16. 10.1002/jbm.a.3624910.1002/jbm.a.36249 ↗
17. 10.3390/min602003410.3390/min6020034 ↗
18. 10.11299/brte.18.34610.11299/brte.18.346 ↗
19. 10.3390/ijerph704134210.3390/ijerph7041342 ↗
20. 10.1016/j.materresbull.2004.10.02010.1016/j.materresbull.2004.10.020 ↗
21. 10.1016/j.actbio.2009.04.01410.1016/j.actbio.2009.04.014 ↗
22. 10.1128/jb.184.4.1140-1154.200210.1128/jb.184.4.1140-1154.2002 ↗
23. 10.1186/1471-2180-13-25710.1186/1471-2180-13-257 ↗
24. 10.1016/j.biomaterials.2005.11.04410.1016/j.biomaterials.2005.11.044 ↗
25. 10.1186/s13037-016-0095-810.1186/s13037-016-0095-8 ↗
26. 10.1146/annurev-micro-102215-09532510.1146/annurev-micro-102215-095325 ↗
27. 10.1016/j.actbio.2007.10.01010.1016/j.actbio.2007.10.010 ↗
28. 10.1007/s10856-007-3213-410.1007/s10856-007-3213-4 ↗
29. 10.1111/j.1551-2916.2006.01396.x10.1111/j.1551-2916.2006.01396.x ↗
30. 10.1016/j.jsb.2016.07.00510.1016/j.jsb.2016.07.005 ↗
31. Boivin G. · Medicographia · 2007 · 29 · 26
32. 10.1021/jp105971s10.1021/jp105971s ↗
33. 10.1021/la804230j10.1021/la804230j ↗
34. 10.2475/ajs.284.1.5810.2475/ajs.284.1.58 ↗
35. 10.1007/bf0255496910.1007/bf02554969 ↗
36. 10.1007/s10856-005-6979-210.1007/s10856-005-6979-2 ↗
37. 10.1002/jbm.a.3418110.1002/jbm.a.34181 ↗
38. 10.1016/8756-3282(95)00101-I10.1016/8756-3282(95)00101-I ↗
39. 10.1016/S0142-9612(03)00487-310.1016/S0142-9612(03)00487-3 ↗
40. 10.1007/s00774-004-0488-010.1007/s00774-004-0488-0 ↗
41. 10.1002/sctm.17-013710.1002/sctm.17-0137 ↗
42. 10.1007/s11010-006-9399-910.1007/s11010-006-9399-9 ↗
43. 10.1039/C5RA07330H10.1039/C5RA07330H ↗
44. 10.1038/nchembio.138210.1038/nchembio.1382 ↗
45. 10.1111/jam.1219710.1111/jam.12197 ↗
46. 10.3389/fcimb.2017.0023310.3389/fcimb.2017.00233 ↗
47. 10.1177/03913988080310090610.1177/039139880803100906 ↗
48. 10.1007/s00198-018-4430-z10.1007/s00198-018-4430-z ↗
49. 10.1016/j.pharmthera.2012.07.00910.1016/j.pharmthera.2012.07.009 ↗
50. 10.1016/j.msec.2013.11.00910.1016/j.msec.2013.11.009 ↗
51. 10.22203/ecm.v008a0510.22203/ecm.v008a05 ↗
52. 10.1111/j.1469-0691.2012.04002.x10.1111/j.1469-0691.2012.04002.x ↗
53. 10.1186/s13054-016-1320-710.1186/s13054-016-1320-7 ↗